Brain microenvironment-driven resistance to immune and targeted therapies in acral melanoma

Rebecca Jane Lee , Garima Khandelwal , Franziska Baenke , Alessio Cannistraci
ESMO Open 5 ( 4)

1
2020
The role of chemotherapy in the modern management of melanoma

Rebecca Jane Lee , Noor Ul-Ain-Tariq , Alberto Fusi , Samantha Bowyer
Melanoma management 1 ( 2) 173 -184

6
2014
Coronavirus Disease 2019: the Pivotal Role of UK Clinical Oncology and the UK Coronavirus Cancer Monitoring Project.

J. Best , T. Starkey , A. Chatterjee , D. Fackrell
Clinical Oncology 33 ( 1)

2021
Outcomes of Peripheral T-cell Lymphoma in the Current Era: 10 Year Experience at The Royal Marsden and Christie Hospitals.

Mark Ethell , Ian Chau , Kim Linton , Andrew Wotherspoon
57th American Society of Hematology Annual Meeting and Exposition

2015
4.33 Characteristics and Outcome of CLL Relapse Post-Fludarabine, Cyclophosphamide ± Rituximab

Dennis A. Carney , Rebecca Lee , Chelsea Hewitt , David S. Ritchie
Clinical Lymphoma Myeloma and Leukemia 11 S241 -S242

2011
All is not lost--the improving outcome of patients with chronic lymphocytic leukaemia failing frontline therapy with fludarabine, cyclophosphamide and rituximab.

Chan Y. Cheah , Thomas E. Lew , Rebecca Lee , Constantine S. Tam
European Journal of Haematology 91 ( 2) 189 -190

2013
Abstract LB-212: Therapeutic efficacy of the paradox-breaking panRAF and SRC drug CCT3833/BAL3833 in KRAS-driven cancer models

Grazia Saturno , Filipa Lopes , Maria Romina Girotti , Ion Niculescu-Duvaz
Cancer Research 76

1
2016
5 YEARS EXPERIENCE OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL): A RETROSPECTIVE PILOT AUDIT

Sayan Datta , Rebecca Lee , Tom Webb , Azzam Ismail
Journal of Neurology, Neurosurgery & Psychiatry 86 ( 11) e4.61 -e4

1
2015
Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma

Maria Romina Girotti , Gabriela Gremel , Rebecca Lee , Elena Galvani
Cancer Discovery 6 ( 3) 286 -299

143
2016
Dabrafenib and its use in the treatment of metastatic melanoma

Samantha Bowyer , Rebecca Lee , Alberto Fusi , Paul Lorigan
Melanoma management 2 ( 3) 199 -208

3
2015
Myosin II reactivation and cytoskeletal remodeling as a hallmark and a vulnerability in melanoma therapy resistance

Jose L. Orgaz , Eva Crosas-Molist , Amine Sadok , Anna Perdrix-Rosell
Cancer Cell 37 ( 1) 85

17
2020
Outcomes following front-line chemotherapy in peripheral T-cell lymphoma: 10-year experience at The Royal Marsden and The Christie Hospital.

Mary Gleeson , Clare Peckitt , David Cunningham , Adam Gibb
Leukemia & Lymphoma 59 ( 7) 1586 -1595

5
2018
Use of circulating tumor DNA to predict survival in patients with resected high-risk stage II/III melanoma.

Rebecca Lee , Gabriela Gremel , Andrea Marshall , Kevin A Myers
Journal of Clinical Oncology 35 9583 -9583

2
2017
Optimal management of immune-related toxicities associated with checkpoint inhibitors in lung cancer.

Matthew Howell , Rebecca Lee , Samantha Bowyer , Alberto Fusi
Lung Cancer 88 ( 2) 117 -123

34
2015
Real-world outcomes of immune-related adverse events in 2,125 patients managed with immunotherapy: A United Kingdom multicenter series.

Anna Claire Olsson-Brown , Mark Baxter , Caroline Dobeson , Laura Feeney
Journal of Clinical Oncology 38 7065 -7065

3
2020
Survival of patients with early invasive melanoma down-staged under the new eighth edition of the American Joint Committee on Cancer staging system

Lena A. von Schuckmann , Maria Celia B. Hughes , Rebecca Lee , Paul Lorigan
Journal of the American Academy of Dermatology 80 ( 1) 272 -274

6
2019
Influence of the MTHFR genotype on the rate of malformations following exposure to antiepileptic drugs in utero.

Usha Kini , Rebecca Lee , Alison Jones , Sarah Smith
European Journal of Medical Genetics 50 ( 6) 411 -420

22
2007
Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism

Cátia Monteiro , Lauritz Miarka , María Perea-García , Neibla Priego
Nature Medicine 28 ( 4) 752 -765

11
2022